- Home
- RCUS vs RDWR Comparison
RCUS vs RDWR Comparison
Compare RCUS & RDWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- RDWR
- Stock Information
- Founded
- RCUS 2015
- RDWR 1996
- Country
- RCUS United States
- RDWR Israel
- Employees
- RCUS N/A
- RDWR N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- RDWR EDP Services
- Sector
- RCUS Health Care
- RDWR Technology
- Exchange
- RCUS Nasdaq
- RDWR Nasdaq
- Market Cap
- RCUS 1.2B
- RDWR 1.2B
- IPO Year
- RCUS 2018
- RDWR 1999
- Fundamental
- Price
- RCUS $17.35
- RDWR $26.56
- Analyst Decision
- RCUS Buy
- RDWR Hold
- Analyst Count
- RCUS 8
- RDWR 3
- Target Price
- RCUS $26.50
- RDWR $32.50
- AVG Volume (30 Days)
- RCUS 1.2M
- RDWR 95.6K
- Earning Date
- RCUS 11-05-2025
- RDWR 10-29-2025
- Dividend Yield
- RCUS N/A
- RDWR N/A
- EPS Growth
- RCUS N/A
- RDWR N/A
- EPS
- RCUS N/A
- RDWR 0.32
- Revenue
- RCUS $262,000,000.00
- RDWR $288,813,000.00
- Revenue This Year
- RCUS N/A
- RDWR $11.14
- Revenue Next Year
- RCUS N/A
- RDWR $7.27
- P/E Ratio
- RCUS N/A
- RDWR $82.13
- Revenue Growth
- RCUS 6.07
- RDWR 11.51
- 52 Week Low
- RCUS $6.50
- RDWR $18.46
- 52 Week High
- RCUS $18.98
- RDWR $31.57
- Technical
- Relative Strength Index (RSI)
- RCUS 64.78
- RDWR 54.89
- Support Level
- RCUS $16.41
- RDWR $24.88
- Resistance Level
- RCUS $18.42
- RDWR $26.34
- Average True Range (ATR)
- RCUS 1.17
- RDWR 0.75
- MACD
- RCUS 0.04
- RDWR -0.01
- Stochastic Oscillator
- RCUS 75.30
- RDWR 54.34
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About RDWR Radware Ltd.
Radware Ltd provides cyber security and application delivery solutions. The company provides solutions for cloud, on-premises, and software-defined data centers (SDDC). The solutions of the company secure the digital experience by providing infrastructure, application, and network protection and availability services to enterprises globally. The business segments of the company are Radware's Core Business and The Hawks' Business. The company derives maximum revenue from Radware's Core Business. It generates the majority of its revenue from the United States.